NDC directory

TRENTAL

Pentoxifylline · Validus Pharmaceuticals LLC · TABLET, EXTENDED RELEASE

30698-006NDABlood Viscosity Reducer [EPC]
Product NDC
30698-006
Generic name
Pentoxifylline
Labeler name
Validus Pharmaceuticals LLC
Brand name
TRENTAL
Finished
true
Listing expiration date
20271231
Marketing category
NDA
Dosage form
TABLET, EXTENDED RELEASE
SPL ID
5b329d9b-a63d-78d7-e063-6294a90a2032
Product type
HUMAN PRESCRIPTION DRUG
Marketing start date
20261001
Product ID
30698-006_5b329d9b-a63d-78d7-e063-6294a90a2032
Application number
NDA018631
Brand name base
TRENTAL
Active ingredients
  1. Name
    PENTOXIFYLLINE
    Strength
    400 mg/1
Packaging
  1. Package NDC
    30698-006-01
    Description
    30 TABLET, EXTENDED RELEASE in 1 BOTTLE (30698-006-01)
    Marketing start date
    20261001
    Sample
    false
  2. Package NDC
    30698-006-02
    Description
    100 TABLET, EXTENDED RELEASE in 1 BOTTLE (30698-006-02)
    Marketing start date
    20261001
    Sample
    false
  3. Package NDC
    30698-006-03
    Description
    500 TABLET, EXTENDED RELEASE in 1 BOTTLE (30698-006-03)
    Marketing start date
    20261001
    Sample
    false
Route
ORAL
Pharm class
Blood Viscosity Reducer [EPC], Hematologic Activity Alteration [PE]
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.